BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33041184)

  • 1. Illicit drug prices and quantity discounts: A comparison between a cryptomarket, social media, and police data.
    Moeller K; Munksgaard R; Demant J
    Int J Drug Policy; 2021 May; 91():102969. PubMed ID: 33041184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing cryptomarkets for drugs. A characterisation of sellers and buyers over time.
    Tzanetakis M
    Int J Drug Policy; 2018 Jun; 56():176-186. PubMed ID: 29449105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reputation transferability across contexts: Maintaining cooperation among anonymous cryptomarket actors when moving between markets.
    Norbutas L; Ruiter S; Corten R
    Int J Drug Policy; 2020 Feb; 76():102635. PubMed ID: 31972474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery dilemmas: How drug cryptomarket users identify and seek to reduce their risk of detection by law enforcement.
    Aldridge J; Askew R
    Int J Drug Policy; 2017 Mar; 41():101-109. PubMed ID: 28089207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncertainty and risk: A framework for understanding pricing in online drug markets.
    Munksgaard R; Tzanetakis M
    Int J Drug Policy; 2022 Mar; 101():103535. PubMed ID: 34902806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Offline constraints in online drug marketplaces: An exploratory analysis of a cryptomarket trade network.
    Norbutas L
    Int J Drug Policy; 2018 Jun; 56():92-100. PubMed ID: 29621742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An island apart? Risks and prices in the Australian cryptomarket drug trade.
    Cunliffe J; Martin J; Décary-Hétu D; Aldridge J
    Int J Drug Policy; 2017 Dec; 50():64-73. PubMed ID: 29055855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. #Drugsforsale: An exploration of the use of social media and encrypted messaging apps to supply and access drugs.
    Moyle L; Childs A; Coomber R; Barratt MJ
    Int J Drug Policy; 2019 Jan; 63():101-110. PubMed ID: 30530252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sellers' risk perceptions in public and private social media drug markets.
    Bakken SA; Demant JJ
    Int J Drug Policy; 2019 Nov; 73():255-262. PubMed ID: 31053409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between cryptomarket drug purchase, social networks and adverse drug events: A cross-sectional study.
    Coney L; Peacock A; Malm A; Munksgaard R; Aldridge J; Ferris JA; Maier LJ; Winstock AR; Barratt MJ
    Int J Drug Policy; 2024 Jan; 123():104258. PubMed ID: 38056221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hidden wholesale: The drug diffusing capacity of online drug cryptomarkets.
    Aldridge J; Décary-Hétu D
    Int J Drug Policy; 2016 Sep; 35():7-15. PubMed ID: 27260863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safer scoring? Cryptomarkets, social supply and drug market violence.
    Barratt MJ; Ferris JA; Winstock AR
    Int J Drug Policy; 2016 Sep; 35():24-31. PubMed ID: 27241015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks, prices, and positions: A social network analysis of illegal drug trafficking in the world-economy.
    Boivin R
    Int J Drug Policy; 2014 Mar; 25(2):235-43. PubMed ID: 24418633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forensic drug intelligence and the rise of cryptomarkets. Part I: Studying the Australian virtual market.
    Broséus J; Morelato M; Tahtouh M; Roux C
    Forensic Sci Int; 2017 Oct; 279():288-301. PubMed ID: 28927690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buying drugs on a Darknet market: A better deal? Studying the online illicit drug market through the analysis of digital, physical and chemical data.
    Rhumorbarbe D; Staehli L; Broséus J; Rossy Q; Esseiva P
    Forensic Sci Int; 2016 Oct; 267():173-182. PubMed ID: 27611957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The success rate of online illicit drug transactions during a global pandemic.
    Bergeron A; Décary-Hétu D; Giommoni L; Villeneuve-Dubuc MP
    Int J Drug Policy; 2022 Jan; 99():103452. PubMed ID: 34597861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Nice people doing shady things': Drugs and the morality of exchange in the darknet cryptomarkets.
    Masson K; Bancroft A
    Int J Drug Policy; 2018 Aug; 58():78-84. PubMed ID: 29870962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crime displacement in digital drug markets.
    Ladegaard I
    Int J Drug Policy; 2019 Jan; 63():113-121. PubMed ID: 30572247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transparency paradox. Building trust, resolving disputes and optimising logistics on conventional and online drugs markets.
    Tzanetakis M; Kamphausen G; Werse B; von Laufenberg R
    Int J Drug Policy; 2016 Sep; 35():58-68. PubMed ID: 26809972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retail price and availability of illicit cannabis in Canada.
    Mahamad S; Hammond D
    Addict Behav; 2019 Mar; 90():402-408. PubMed ID: 30530299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.